Introduction
============

Acute lung injury (ALI) is a clinical syndrome associated with respiratory dysfunction, which is caused by numerous local or systemic inflammatory stimuli. ALI is predominantly caused by sepsis, and the rate of ALI-associated mortality is 50-60% ([@b1-mmr-11-06-4239]).

Considerable experimental and clinical evidence has demonstrated that pro- and anti-inflammatory cytokines exhibit a major role in the pathogenesis of inflammatory-induced ALI ([@b2-mmr-11-06-4239]-[@b4-mmr-11-06-4239]). Numerous key genes and potential treatments for ALI have been proposed. Abraham *et al* ([@b5-mmr-11-06-4239]) previously reported that high mobility group protein-1 is a distal mediator of inflammatory ALI. Furthermore, Imai *et al* ([@b6-mmr-11-06-4239]) indicated that the Toll-like receptor 4 signaling pathway has a key role in ALI. Mei *et al* ([@b7-mmr-11-06-4239]) demonstrated that mesenchymal stem cells overexpressing angiopoietin 1 were able to prevent lipopolysaccharide (LPS)-induced ALI in mice. In addition, caspase inhibitor ([@b8-mmr-11-06-4239]), urinary trypsin inhibitor ([@b9-mmr-11-06-4239]) and sphingosine 1-phosphate ([@b10-mmr-11-06-4239]) have been shown to exhibit protective functions in LPS-induced ALI.

LPS is a major bioactive component of endotoxin, which can lead to sepsis and ALI ([@b11-mmr-11-06-4239]). Rittirsch *et al* ([@b12-mmr-11-06-4239]) previously reported that the migration inhibitory factor and leukotriene B~4~ mediator pathways are involved in the immunopathogenesis of LPS-induced experimental ALI; however, complement activation did not contribute to the development of ALI in an LPS model.

For patients with severely impaired respiratory function, mechanical ventilation (MV) is an essential means of treatment ([@b13-mmr-11-06-4239],[@b14-mmr-11-06-4239]). MV provides effective respiratory support; however, it may also result in severe lung damage ([@b15-mmr-11-06-4239],[@b16-mmr-11-06-4239]). Ranieri *et al* ([@b17-mmr-11-06-4239]) previously verified that MV is able to induce a cytokine response, which may be attenuated by therapeutic strategies that minimize overdistention and recruitment/derecruitment of the lung. Therefore, determining the similarities and differences between MV- and LPS-induced ALI is required in order to produce more effective and safe treatment.

In the present study, gene expression profiles of mice with ALI induced by MV, LPS and MV+LPS were compared with controls, in order to identify differentially expressed genes (DEGs). Unique DEGs for each treatment group were screened, and the differences in the induction mechanisms between the groups were discussed.

Materials and methods
=====================

Gene expression data
--------------------

The GSE2411 microarray data set ([@b18-mmr-11-06-4239]) was downloaded from the Gene Expression Omnibus ([@b19-mmr-11-06-4239]). Raw data were collected from 24 C57/B6 male mice, which were randomly divided into four groups: Control, phosphate-buffered saline (PBS) aspiration without MV; MV treatment, PBS with MV; LPS treatment, LPS aspiration without MV; and MV+LPS treatment. The annotation information for the chip was downloaded from the Mouse Expression 430A Array (GPL339 platform; Affymetrix, Santa Clara, CA, USA).

Data pre-treatment and differential analysis
--------------------------------------------

The probes were mapped to genes according to the annotation files. When numerous probes were mapped to a single gene the values were averaged, in order to obtain the final expression levels. Log~2~ transformation and quantile normalization of the gene expression levels were conducted using the affy package ([@b20-mmr-11-06-4239]) of *R* software (<http://www.R-project.org>). The three experimental groups were compared with the control group: Control vs. MV group; control vs. LPS group; and control vs. MV+LPS group. Statistical analyses were conducted using the multtest package ([@b21-mmr-11-06-4239]) of *R* software, and numerous testing corrections were conducted using the Benjamin-Hochberg method ([@b22-mmr-11-06-4239]). A false discovery rate (FDR)\<0.05 and \|logFC\|\>1 were set as the cut-off values, in order to screen for DEGs.

Cluster analysis
----------------

Hierarchical clustering ([@b23-mmr-11-06-4239]) was performed for the DEGs identified from the three groups using *cluster* 3.0 program (version 1.47; <http://rana.lbl.gov/EisenSoftware.html>). The results were then visualized using Tree view program (<http://rana.lbl.gov/EisenSoftware.html>) ([@b23-mmr-11-06-4239]).

Between-group comparisons of the DEGs
-------------------------------------

Student's t-test ([@b24-mmr-11-06-4239]) was used to examine the differences in the gene expression levels of the DEGs between the three experimental groups. P\<0.05 was considered to indicate a statistically significant difference, and was used as a threshold value.

Functional enrichment analysis
------------------------------

To identify the altered biological functions following the various treatments, a functional enrichment analysis was conducted for the DEGs using the Database for Annotation, Visualization and Integrated Discovery (DAVID; <http://www.david.niaid.nih.gov>) ([@b25-mmr-11-06-4239]). An FDR\<0.05 was set as the cut-off value.

Screening of unique DEGs
------------------------

The three experimental groups of DEGs were compared, in order to screen for unique DEGs in each experimental group (MV, LPS and MV+LPS groups). The unique DEGs were used to identify the molecular mechanism of ALI, induced by the corresponding treatment.

Pathway enrichment analysis of the unique DEGs
----------------------------------------------

A pathway enrichment analysis of the unique DEGs was conducted using the Kyoto Encyclopedia of Genes and Genomes Orthology Based Annotation system (KOBAS; <HTTP://KOBAS.CBI.PKU.EDU.CN>) ([@b26-mmr-11-06-4239]--[@b27-mmr-11-06-4239]). An FDR\<0.05 was set as the cut-off value.

Results
=======

DEGs
----

The normalized gene expression data are presented in [Fig. 1](#f1-mmr-11-06-4239){ref-type="fig"}. A total of 32, 264 and 685 DEGs were identified in the MV, LPS and MV+LPS groups, as compared with the control group, respectively. Transcriptional response was detected in each group. Treatment with MV generated the smallest number of DEGs, followed by LPS treatment. Simultaneous application of the two treatments resulted in a significant increase in the transcriptional response.

Cluster analysis results
------------------------

The cluster analysis results are shown in the upper section of [Fig. 2](#f2-mmr-11-06-4239){ref-type="fig"}. Each group of DEGs could be used to distinguish the corresponding experimental group from the control group. The MV group ([Fig. 2A](#f2-mmr-11-06-4239){ref-type="fig"}) had fewer DEGs, as compared with the LPS and MV+LPS groups ([Fig. 2B and C](#f2-mmr-11-06-4239){ref-type="fig"}).

Results of between-group comparisons
------------------------------------

The expression levels of the DEGs in each experimental group were compared using a Student's t-test ([@b24-mmr-11-06-4239]). The results are presented in the lower section of [Fig. 2](#f2-mmr-11-06-4239){ref-type="fig"}. The MV+LPS group exhibited the highest degree of overexpression, as compared with the other groups. This result is concordant with the cluster analysis. A combination of MV and LPS stimulated the strongest transcriptional response in the lungs of the mice.

Functional enrichment analysis results
--------------------------------------

A Gene Ontology enrichment analysis was performed using DAVID, and the top 10 terms that met the threshold value (P\<0.05) are presented in [Table I](#tI-mmr-11-06-4239){ref-type="table"}. Negative regulation of catalytic activity was the most significantly enriched term in the MV group. Whereas, immune response was the most significantly enriched term in the LPS and MV+LPS groups, suggesting that LPS dominated the stimulation process of ALI. LPS increased the expression of genes associated with the immune and inflammatory response, whereas MV aggravated this effect.

Unique DEGs in each experimental group
--------------------------------------

The three groups of DEGs were compared, in order to identify unique DEGs in each experimental group. A total of 421 unique DEGs were identified in the MV+LPS group, as compared with MV and LPS groups, whereas 246 unique DEGs were identified in the LPS group, as compared with the MV group ([Fig. 3](#f3-mmr-11-06-4239){ref-type="fig"}).

Pathway enrichment analysis results
-----------------------------------

A pathway enrichment analysis was performed for the two groups of unique DEGs (LPS-unique and MV+LPS-unique), using KOBAS. The overrepresented pathways are presented in [Table II](#tII-mmr-11-06-4239){ref-type="table"}. Cytokine-cytokine receptor interaction was the most significantly enriched term in both groups of unique DEGs. The Janus kinase-signal transducer and activator of transcription (Jak-STAT) signaling pathway was enriched for in the LPS+MV-unique DEGs.

Discussion
==========

The present study identified 32, 264 and 685 DEGs in the MV, LPS, and MV+LPS groups, respectively. The transcriptional response of the lungs was observed in the MV and LPS treatment groups; however, the MV+LPS generated the most DEGs, thus suggesting that MV is able to augment the influence of LPS on gene expression. MV exerted a smaller disturbance on the transcription of genes in the lungs, as compared with LPS, which was further verified by a cluster analysis and between-group comparisons. The underlying mechanism of the effects of MV was obviously different from that of LPS. Negative regulation of catalytic activity was the most significant biological process enriched for in the DEGs of MV, whereas the immune and inflammatory response were the most significantly enriched terms in the DEGs of the LPS and MV+LPS groups.

In order to further determine the differences between the two treatments in causing ALI, the identified DEGs from each experimental group were compared. A total of 246 out of the 264 identified DEGs were unique to the LPS group, as compared with the MV group. A total of 421 novel DEGs were identified in the MV+LPS group, as compared with the MV and LPS groups. Cytokine-cytokine receptor interaction was the most significantly enriched pathway in the LPS-unique and MV+LPS-unique DEGs, which verified the role of the inflammatory response in the pathogenesis of ALI. This result also suggested that MV could exaggerate the degree of inflammation in the lungs, as more cytokines were dysregulated.

Cytokines are synthesized and secreted by inflammatory cells, and have a wide range of biological activities. Cytokines are involved in the regulation of immune cell differentiation and development, and the immune and inflammatory response ([@b28-mmr-11-06-4239]). They are considered to have important roles in ALI ([@b29-mmr-11-06-4239]). In the present study, members of the CXC subfamily, CC subfamily, tumor necrosis factor (TNF)-receptor superfamily and interleukin (IL)-1 cytokine family were shown to be differentially expressed. Chemokine (C-X-C motif) ligand 1 (CXCL1) has previously been shown to have a role in inflammation, and functions as a chemoattractant for neutrophils ([@b30-mmr-11-06-4239],[@b31-mmr-11-06-4239]). In addition, IL-6 is secreted into the serum, and induces a transcriptional inflammatory response through IL-6 receptor α ([@b32-mmr-11-06-4239],[@b33-mmr-11-06-4239]). Ahuja *et al* ([@b34-mmr-11-06-4239]) previously reported that circulating IL-6 mediates lung injury, via CXCL1 production following acute kidney injury in mice. IL-1β is a family of proinflammatory cytokines, which are hypothesized to be involved in numerous acute and chronic diseases ([@b35-mmr-11-06-4239]). Kolb *et al* ([@b36-mmr-11-06-4239]) previously demonstrated that transient expression of IL-1β was able to induce ALI. Furthermore, CCL2 is involved in inflammatory disorders of the lung, and it has been suggested that it may contribute to ALI ([@b37-mmr-11-06-4239]). Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with ALI ([@b38-mmr-11-06-4239]). Furthermore, numerous members of the colony stimulating factors (CSFs) were identified in ALI in the present study, such as CSF1, CSF2 and CSF3. CSFs have been shown to exhibit protective effects on ALI ([@b39-mmr-11-06-4239]-[@b41-mmr-11-06-4239]). These results suggest that the findings of the present study may be useful in guiding the further investigation of ALI.

The Jak-STAT signaling pathway was shown to be enriched in the MV+LPS-unique DEGs. The Jak-STAT pathway participates in transcriptional activation in response to interferons, and other extracellular signaling proteins ([@b42-mmr-11-06-4239]). It is important in regulating cytokine-dependent gene expression, and cellular development and survival ([@b43-mmr-11-06-4239]). Previous studies have demonstrated that the STAT pathway is activated in ALI ([@b44-mmr-11-06-4239]-[@b45-mmr-11-06-4239]). Severgnini *et al* ([@b46-mmr-11-06-4239]) previously showed that inhibition of Src and Jak kinases resulted in protection against LPS-induced ALI. Therefore, the present study hypothesized that DEGs associated with this pathway may be potential therapeutic targets. CSF3 is a cytokine that controls the production, differentiation, and function of granulocytes ([@b47-mmr-11-06-4239]). Hierholzer *et al* ([@b48-mmr-11-06-4239]) reported that the presence of G-CSF alone in the lung can lead to the recruitment of neutrophils, lung injury, and impaired pulmonary function, thus suggesting that the local production of G-CSF may contribute to the development of lung damage and possibly ALI. Furthermore, Suratt *et al* ([@b49-mmr-11-06-4239]) showed that plasma levels of G-CSF correlate with clinical outcomes in patients with ALI. Pim kinases are a family of serine/threonine kinases whose activity can be induced by allergy-associated cytokines ([@b50-mmr-11-06-4239]). Shin *et al* ([@b50-mmr-11-06-4239]) previously reported that inhibition of Pim1 kinase activation attenuated allergen-induced airway hyperresponsiveness and inflammation. Therefore, Pim1 may exert similar functions in ALI and could be a potential therapeutic target.

Fatty acid metabolism was also found to be significantly enriched for in the MV+LPS-unique DEGs. Murray *et al* ([@b51-mmr-11-06-4239]) demonstrated that select dietary fatty acids are able to attenuate cardiopulmonary dysfunction, during ALI in pigs. However, Rice *et al* ([@b52-mmr-11-06-4239]) reported that twice-daily enteral supplementation of omega-3 fatty acids, γ-linolenic acid and antioxidants did not improve the primary end-point of ventilator-free days, or other clinical outcomes in patients with ALI, and may be harmful. Therefore, although certain findings have been obtained, the association between fatty acid metabolism and ALI remains under debate.

In conclusion, the present study discussed the similarities and differences between MV- and LPS-induced ALI. These findings not only supplement the current knowledge regarding ALI, but may also provide potential biomarkers for the diagnosis and treatment of ALI.
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###### 

Overrepresented biological processes in each group of differentially expressed genes.

  A, Control-MV                                                   
  ------------------------------------------------------- ------- ----------
  GO:0043086\~negative regulation of catalytic activity   5       3.23E-05
  GO:0044092\~negative regulation of molecular function   5       9.19E-05
  GO:0030595\~leukocyte chemotaxis                        2       4.86E-02
  GO:0060326\~cell chemotaxis                             2       4.86E-02
                                                                  
  B, Control-LPS                                                  
                                                                  
  Term                                                    Count   FDR
                                                                  
  GO:0006955\~immune response                             60      5.94E-34
  GO:0006952\~defense response                            51      1.07E-25
  GO:0009611\~response to wounding                        45      1.62E-24
  GO:0006954\~inflammatory response                       38      3.02E-24
  GO:0007610\~behavior                                    28      3.39E-07
  GO:0007626\~locomotory behavior                         27      9.83E-12
  GO:0042127\~regulation of cell proliferation            27      5.45E-04
  GO:0006935\~chemotaxis                                  26      2.59E-19
  GO:0042330\~taxis                                       26      2.59E-19
  GO:0010033\~response to organic substance               23      2.44E-02
                                                                  
  C, Control-MV+LPS                                               
                                                                  
  Term                                                    Count   FDR
                                                                  
  GO:0006955\~immune response                             87      3.50E-32
  GO:0009611\~response to wounding                        68      7.48E-26
  GO:0006954\~inflammatory response                       54      2.80E-24
  GO:0006952\~defense response                            70      1.19E-20
  GO:0042330\~taxis                                       32      7.08E-16
  GO:0006935\~chemotaxis                                  32      7.08E-16
  GO:0042127\~regulation of cell proliferation            62      2.63E-11
  GO:0007626\~locomotory behavior                         34      2.40E-07
  GO:0001775\~cell activation                             33      2.13E-06
  GO:0001817\~regulation of cytokine production           24      4.65E-06

MV, mechanical ventilation; LPS, lipopolysaccharide; Count, number of enriched differentially expressed genes; FDR, false discovery rate.

###### 

Overrepresented pathways in the two groups of unique differentially expressed genes.

  A, LPS-unique                                                        
  ------------------ ----------------------------------------- ------- ----------
  mmu04060           Cytokine-cytokine receptor interaction    30      2.44E-13
  mmu04062           Chemokine signaling pathway               19      4.93E-06
  mmu04621           NOD-like receptor signaling pathway       12      1.42E-05
  mmu04620           Toll-like receptor signaling pathway      13      2.48E-04
                                                                       
  B, LPS+MV-unique                                                     
                                                                       
  Pathway ID         Pathway name                              Count   FDR
                                                                       
  mmu04060           Cytokine-cytokine receptor interaction    22      1.62E-05
  mmu04062           Chemokine signaling pathway               14      3.88E-03
  mmu04630           Jak-STAT signaling pathway                12      7.01E-03
  mmu04620           Toll-like receptor signaling pathway      9       1.10E-02
  mmu00760           Nicotinate and nicotinamide metabolism    4       4.03E-02
  mmu00071           Fatty acid metabolism                     5       4.89E-02
  mmu01040           Biosynthesis of unsaturated fatty acids   4       4.91E-02

LPS, lipopolysaccharide; MV, mechanical ventilation; Count, number of enriched differentially expressed gene; FDR, false discovery rate.
